Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. decreased its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 674,402 shares of the company’s stock after selling 9,362 shares during the period. Victory Capital Management Inc. owned approximately 1.36% of Prestige Consumer Healthcare worth $41,287,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of PBH. Ariel Investments LLC boosted its holdings in Prestige Consumer Healthcare by 173.8% in the 3rd quarter. Ariel Investments LLC now owns 2,534,786 shares of the company’s stock worth $144,964,000 after acquiring an additional 1,609,044 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in shares of Prestige Consumer Healthcare by 19.1% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,087,821 shares of the company’s stock valued at $62,213,000 after purchasing an additional 174,416 shares during the period. Brandes Investment Partners LP grew its holdings in Prestige Consumer Healthcare by 138.6% during the 3rd quarter. Brandes Investment Partners LP now owns 129,084 shares of the company’s stock valued at $7,382,000 after purchasing an additional 74,982 shares in the last quarter. Advisors Preferred LLC purchased a new stake in Prestige Consumer Healthcare during the 4th quarter worth $2,447,000. Finally, Qube Research & Technologies Ltd lifted its holdings in Prestige Consumer Healthcare by 91.4% in the 3rd quarter. Qube Research & Technologies Ltd now owns 72,092 shares of the company’s stock worth $4,123,000 after buying an additional 34,430 shares in the last quarter. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

Shares of Prestige Consumer Healthcare stock opened at $70.00 on Monday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.92 and a current ratio of 3.09. Prestige Consumer Healthcare Inc. has a 1 year low of $55.96 and a 1 year high of $75.31. The firm’s 50-day simple moving average is $71.12 and its 200-day simple moving average is $64.66.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 8th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.02. The firm had revenue of $282.74 million for the quarter, compared to analysts’ expectations of $280.25 million. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. Prestige Consumer Healthcare’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.04 earnings per share. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current year.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 5,336 shares of the business’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $69.00, for a total transaction of $368,184.00. Following the completion of the sale, the senior vice president now owns 15,934 shares in the company, valued at $1,099,446. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. TheStreet upgraded Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research note on Monday, February 12th. StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 10th. One analyst has rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $110.00.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.